论文部分内容阅读
一年来我参加了在韩国、美国、瑞士(WHO 总部)和菲律宾(WHO西太区)举行的国际麻风会议,现就其重点分三部分加以简略介绍: I、免疫学研究至今麻风菌(ML)尚未培养成功,但从接种的犰狳组织中已分离出大量麻风菌,并从中提取了酚糖酯(PGL)和多种蛋白抗原。不过仍未达到预定的目标,即一早期诊断和预测复发;—流行病学(传播方式)的研究;—检测耐药菌株;—鉴定个体对麻风的免疫性;—揭示I型麻风反应(RR)和Ⅱ型麻风反应(ENL)与神经损害的免疫病理机制。对免疫诊断的研究大致有: 1.ML抗原的检测:患者血浆和尿中的
In the past year, I participated in the International Conference on Leprosy in South Korea, the United States, Switzerland (WHO headquarters) and the Philippines (WHO Western Pacific Region), and I briefly introduce the following three parts: I. Immunological Studies Leprosy (ML ) Have not yet been successfully cultivated but a large number of leprosy have been isolated from the inoculated armadillo tissues and phenolic sugar esters (PGLs) and various protein antigens have been extracted therefrom. But still not achieving the intended goal of an early diagnosis and prediction of recurrence; - studies in epidemiology (modes of transmission); - detection of resistant strains; - identification of individual immunity to leprosy; - disclosure of type I leprosy response ) And type II leprosy reaction (ENL) and neural damage immunopathological mechanisms. The immune diagnosis of the study are: 1.ML antigen detection: the patient’s plasma and urine